| Literature DB >> 32787463 |
Sheron Campos Cogo1, Thatyanne Gradowski Farias da Costa do Nascimento1, Fernanda de Almeida Brehm Pinhatti1, Nilton de França Junior1, Bruna Santos Rodrigues1, Luciane Regina Cavalli2,3, Selene Elifio-Esposito1.
Abstract
This review was conducted to present the main neuroblastoma (NB) clinical characteristics and the most common genetic alterations present in these pediatric tumors, highlighting their impact in tumor cell aggressiveness behavior, including metastatic development and treatment resistance, and patients' prognosis. The distinct three NB cell lineage phenotypes, S-type, N-type, and I-type, which are characterized by unique cell surface markers and gene expression patterns, are also reviewed. Finally, an overview of the most used NB cell lines currently available for in vitro studies and their unique cellular and molecular characteristics, which should be taken into account for the selection of the most appropriate model for NB pre-clinical studies, is presented. These valuable models can be complemented by the generation of NB reprogrammed tumor cells or organoids, derived directly from patients' tumor specimens, in the direction toward personalized medicine.Entities:
Keywords: Pediatric cancer; SH-SY5Y; in vitro models; neural crest tumors; neuroblastoma cell lines; tumor stem cells
Year: 2020 PMID: 32787463 PMCID: PMC7802384 DOI: 10.1177/1535370220949237
Source DB: PubMed Journal: Exp Biol Med (Maywood) ISSN: 1535-3699